Melphalan Capsule

Melphalan functions as a potent bifunctional alkylating agent that achieves therapeutic synergy through the formation of interstrand DNA cross-links, effectively inhibiting nucleic acid synthesis and promoting apoptosis in malignant cell populations. The capsule delivery system provides a critical clinical benefit by enabling convenient outpatient management and flexible dosing schedules, which reduces the burden of frequent hospital visits and avoids the complications associated with prolonged intravenous access. This oral formulation ensures reliable systemic exposure for the treatment of multiple myeloma and advanced ovarian adenocarcinoma, balancing high-efficacy cytotoxic action with a delivery method that prioritizes patient autonomy and treatment compliance.